Harwood Feffer LLP Announces Investigation of Accretive Health, Inc.
NEW YORK, April 25, 2012 /PRNewswire/ — Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Accretive Health, Inc. (“Accretive Health” or the “Company”) (NYSE: AH), concerning whether the board has breached its fiduciary duties to shareholders.
On January 19, 2012, the Attorney General of Minnesota filed a complaint against Accretive Health in the United States District Court for the District of Minnesota, Case No., 12-cv-00145, alleging, among other things, that the Company had engaged in systematic and widespread violations of state and federal debt collection acts and patient privacy laws.
On April 24, 2012, the New York Times published an article reporting in detail on the allegations against the Company. On this news, Accretive Health shares were down as much as 31% in midday trading on April 25, 2012.
Our investigation concerns whether the Accretive Health board of directors has breached its fiduciary duties to shareholders, grossly mismanaged the Company, and/or committed abuses of control in connection with the foregoing.
If you own Accretive Health shares and wish to discuss this matter with us, or have any questions concerning your rights and interests with regard to this matter, please contact:
Robert I. Harwood, Esq.
Matthew M. Houston, Esq.
Harwood Feffer LLP
488 Madison Avenue
New York, New York 10022
Phone Numbers: (877) 935-7400
Harwood Feffer has been representing individual and institutional investors for many years, serving as lead counsel in numerous cases in federal and state courts. Please visit the Harwood Feffer LLP website (http://www.hfesq.com) for more information about the firm.
Attorney Advertising. © 2011 Harwood Feffer LLP. The law firm responsible for this advertisement is Harwood Feffer LLP (www.hfesq.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter.
SOURCE Harwood Feffer LLP